A New Era in Influenza: Differential Diagnosis and Antiviral Selection in the Complex COVID-19 Landscape
September 30, 2021
September 30, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Global Education Group and Paradigm Medical Communications, LLC..
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
- PA Continuing Education — maximum of 1.00 AAPA Category 1 CME credit
- Nurse Practitioner Continuing Education — 1.0 contact hour of continuing education
All other healthcare professionals completing this course will be issued a statement of participation.
This activity has been designed to address the educational needs of nurse practitioners (NPs) and PAs who practice across a range of healthcare settings, many of which accommodate a high volume of patients who are at high risk for influenza-related complications (e.g., primary care, infectious diseases, women’s health, pediatrics, and geriatrics). It might also benefit other clinicians who are involved or interested in the prevention and management of influenza.
With a growing national shortage of primary care physicians, today’s complex and dynamic healthcare environment increasingly places NPs and PAs as front-and-center clinical managers of infectious diseases like influenza and the global COVID-19 (SARS-CoV-2) pandemic makes these frontline clinicians more important than ever before. Influenza and SARS-CoV-2 viruses can cause similar symptoms, making differential diagnosis difficult and even more confounding to clinicians, patients can be coinfected with both SARS-CoV-2 and influenza viruses simultaneously. The global impact of COVID-19 has resulted in rapid, ongoing changes to influenza practice guidelines. This educational activity will provide a concise, case-based, expert-led review of the latest clinical practices and best available evidence for effective influenza management, targeted to the unique needs of NPs and PAs.
After completing this activity, the participant should be better able to:
- Recognize patients who would most benefit from antiviral therapy based on risk of influenza-related complications, in accordance with evolving recommendations in the COVID-19 era
- Distinguish influenza from other viral infections in patients based on signs, symptoms, and test results in the COVID-19 era
- Develop individualized antiviral treatment plans that are safe and effective for patients with, or at risk of, influenza and/or possible co-infections in the rapidly evolving COVID-19 era
Ruth Carrico, PhD, DNP, APRN, CIC, FSHEA, FNAP
Professor, Division of Infectious Diseases
University of Louisville School of Medicine
Laura Gunder McClary, DHSc, MHE, PA-C, CLS (ASCP)
Rocky Mountain University of Health Professions
Director of Health Education Track
Doctor of Medical Science
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
UC Irvine Program in Medical Education for the Latino Community (PRIME-LC)
Santa Ana, CA
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Paradigm Medical Communications, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.4 hours of pharmacology).
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 9/30/2021 to 9/30/2022. AAPA reference number: CME-203509.
Disclosures of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
|Name of Faculty or Presenter||Reported Financial Relationship|
|Ruth Lynne Carrico||Consulting Fees (e.g., Advisory Board): |
Novavax; Pfizer Inc.; Sanofi Pasteur
Speaker’s Bureau: Pfizer Inc.; Sanofi Pasteur
Grant/Research Support: Johnson &
|Laura Gunder McClary||Nothing to disclose|
|Charles Vega||Consulting Fees (e.g., Advisory Board): |
GlaxoSmithKline; Johnson & Johnson
The planners and managers have the following relevant financial relationships with ineligible companies:
|Name of Planner or Manager||Reported Financial Relationship|
|Kristin Delisi, NP||Nothing to disclose|
|Lindsay Borvansky||Nothing to disclose|
|Andrea Funk||Nothing to disclose|
|Liddy Knight||Nothing to disclose|
|Ashley Cann||Nothing to disclose|
|Paradigm Medical Communications, LLC staff members||Nothing to disclose|
Instructions for Participation and Credit
To receive a CME certificate of participation, you should:
- Follow instructions to register or log in with your professional information and complete the preactivity assessment
- View the online activity in its entirety
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or email@example.com.
There is no fee required for participation in this activity.
Course Viewing Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader.
If you have any technical problems or playback issues, email us at firstname.lastname@example.org.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Paradigm Medical Communications do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/Safeguarding Personal Information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and Use of Your Personal Information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
©2021 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.
If you have any questions or comments, please email us at email@example.com.